Personalis CEO exercises options, sells 100K shares
Personalis, Inc. Chief Executive Officer Christopher M. Hall reported an exercise-and-sell transaction in company stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Personalis, Inc. Chief Executive Officer Christopher M. Hall reported an exercise-and-sell transaction in company stock. He exercised stock options to acquire 100,000 shares of common stock at $1.61 per share, then sold 100,000 shares of common stock in an open-market transaction at a weighted average price of $13.15 per share, with sale prices ranging from $13.00 to $13.36.
Following these transactions, Hall directly holds 235,986 shares of Personalis common stock and 200,000 stock options. The filing states that both the sales and the option exercise were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on December 17, 2025, indicating the activity was scheduled in advance.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 100,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 100,000 | $1.61 | $161K |
| Sale | Common Stock | 100,000 | $13.15 | $1.31M |
Footnotes (3)
- F1. The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2025.
- F2. The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $13.00 to $13.36 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- F3. The option vested and became exercisable over the three-year period commencing April 15, 2024, with 1/36th of the shares subject to the option vesting each month of continuous service thereafter.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
Stock Option (right to buy) financial
vesting financial
open-market sale financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Personalis (PSNL) CEO Christopher Hall report in this Form 4?
What stock options did the Personalis (PSNL) CEO exercise in this transaction?
Was the Personalis (PSNL) CEO’s stock sale part of a Rule 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.